Méndez-Blanco Carolina, Fernández-Palanca Paula, Fondevila Flavia, González-Gallego Javier, Mauriz José L
Institute of Biomedicine (IBIOMED), University of León, León, Spain.
Institute of Biomedicine (IBIOMED), University of León, Campus of Vegazana s/n, León 24071, Spain.
Ther Adv Med Oncol. 2021 Feb 7;13:1758835920987071. doi: 10.1177/1758835920987071. eCollection 2021.
Hepatocellular carcinoma (HCC) is a highly recurrent tumor after resection and has been closely related to hypoxia. Hypoxia-inducible factors 1α and 2α (HIF-1α and HIF-2α) have been shown to contribute to tumor progression and therapy resistance in HCC. We evaluated the prognostic and clinicopathological significance of HIF-1α and HIF-2α in HCC patients.
We systematically searched Embase, Cochrane, PubMed, Scopus and Web of Science (WOS) from inception to 1 June 2020 for studies evaluating HIF-1α and/or HIF-2α expression in HCC. Selected articles evaluate at least one factor by immunohistochemistry (IHC) in HCC patients who underwent surgical resection, and its relationship with prognosis and/or clinicopathological features. Study protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO; CDR42020191977). We meta-analyzed the data extracted or estimated according to the Parmar method employing STATA software. We evaluated the overall effect size for the hazard ratio (HR) and odds ratio (OR) with 95% confidence interval (CI), as well as heterogeneity across studies with the statistic and chi-square-based Q test. Moreover, we conducted subgroup analysis when heterogeneity was substantial. Publication bias was assessed by funnel plot asymmetry and Egger's test.
HIF-1α overexpression was correlated with overall survival (OS), disease-free survival (DFS)/recurrence-free survival (RFS) and clinicopathological features including Barcelona Clinic Liver Cancer (BCLC), capsule infiltration, intrahepatic metastasis, lymph node metastasis, tumor-node-metastasis (TNM), tumor differentiation, tumor number, tumor size (3 cm), vascular invasion and vasculogenic mimicry. We also detected a possible correlation of HIF-1α with alpha-fetoprotein (AFP), cirrhosis, histological grade, tumor size (5 cm) and albumin after subgroup analysis. Initially, only DFS/RFS appeared to be associated with HIF-2α overexpression. Subgroup analysis denoted that HIF-2α overexpression was related to OS and capsule infiltration.
HIF-1α and HIF-2α overexpression is related to poor OS, DFS/RFS and some clinicopathological features of HCC patients, suggesting that both factors could be useful HCC biomarkers.
肝细胞癌(HCC)是一种切除术后极易复发的肿瘤,且与缺氧密切相关。缺氧诱导因子1α和2α(HIF-1α和HIF-2α)已被证明在HCC的肿瘤进展和治疗抵抗中起作用。我们评估了HIF-1α和HIF-2α在HCC患者中的预后及临床病理意义。
我们系统检索了Embase、Cochrane、PubMed、Scopus和Web of Science(WOS)数据库,检索时间从建库至2020年6月1日,以查找评估HCC中HIF-1α和/或HIF-2α表达的研究。入选文章通过免疫组织化学(IHC)评估至少一种因子在接受手术切除的HCC患者中的表达,及其与预后和/或临床病理特征的关系。研究方案已在国际前瞻性系统评价注册库(PROSPERO;CDR42020191977)中注册。我们使用STATA软件根据Parmar方法对提取或估算的数据进行荟萃分析。我们评估了风险比(HR)和比值比(OR)的总体效应大小及95%置信区间(CI),并通过I²统计量和基于卡方的Q检验评估研究间的异质性。此外,当异质性显著时,我们进行了亚组分析。通过漏斗图不对称性和Egger检验评估发表偏倚。
HIF-1α过表达与总生存期(OS)、无病生存期(DFS)/无复发生存期(RFS)以及临床病理特征相关,包括巴塞罗那临床肝癌分期(BCLC)、包膜浸润、肝内转移、淋巴结转移、肿瘤-淋巴结-转移分期(TNM)、肿瘤分化程度、肿瘤数量、肿瘤大小(3 cm)、血管侵犯和血管生成拟态。亚组分析后,我们还检测到HIF-1α与甲胎蛋白(AFP)、肝硬化、组织学分级、肿瘤大小(5 cm)和白蛋白之间可能存在的相关性。最初,只有DFS/RFS似乎与HIF-2α过表达相关。亚组分析表明,HIF-2α过表达与OS和包膜浸润有关。
HIF-1α和HIF-2α过表达与HCC患者的不良OS、DFS/RFS及一些临床病理特征相关,提示这两个因子可能都是有用的HCC生物标志物。